On January 16, 2026, the company announced that it has granted a total of 8 million restricted share units under its post-initial public offering equity incentive plan. These units, equivalent to 8 million ordinary shares with a par value of US$0.0001 each in the company's share capital, were awarded to two grantees. The recipients include one employee of the group and a service provider, Whitcup Life Sciences LLC. The grants are conditional upon acceptance by the respective grantees to become effective.